Literature DB >> 27050523

Multiphasic and Dynamic Changes in Alternative Splicing during Induction of Pluripotency Are Coordinated by Numerous RNA-Binding Proteins.

Benjamin Cieply1, Juw Won Park2, Angela Nakauka-Ddamba3, Thomas W Bebee1, Yang Guo4, Xuequn Shang5, Christopher J Lengner3, Yi Xing6, Russ P Carstens7.   

Abstract

Alternative splicing (AS) plays a critical role in cell fate transitions, development, and disease. Recent studies have shown that AS also influences pluripotency and somatic cell reprogramming. We profiled transcriptome-wide AS changes that occur during reprogramming of fibroblasts to pluripotency. This analysis revealed distinct phases of AS, including a splicing program that is unique to transgene-independent induced pluripotent stem cells (iPSCs). Changes in the expression of AS factors Zcchc24, Esrp1, Mbnl1/2, and Rbm47 were demonstrated to contribute to phase-specific AS. RNA-binding motif enrichment analysis near alternatively spliced exons provided further insight into the combinatorial regulation of AS during reprogramming by different RNA-binding proteins. Ectopic expression of Esrp1 enhanced reprogramming, in part by modulating the AS of the epithelial specific transcription factor Grhl1. These data represent a comprehensive temporal analysis of the dynamic regulation of AS during the acquisition of pluripotency.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27050523      PMCID: PMC5718363          DOI: 10.1016/j.celrep.2016.03.025

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  28 in total

1.  Interaction between the two ubiquitously expressed transcription factors NF-Y and Sp1.

Authors:  K Roder; S S Wolf; K J Larkin; M Schweizer
Journal:  Gene       Date:  1999-06-24       Impact factor: 3.688

2.  An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming.

Authors:  Mathieu Gabut; Payman Samavarchi-Tehrani; Xinchen Wang; Valentina Slobodeniuc; Dave O'Hanlon; Hoon-Ki Sung; Manuel Alvarez; Shaheynoor Talukder; Qun Pan; Esteban O Mazzoni; Stephane Nedelec; Hynek Wichterle; Knut Woltjen; Timothy R Hughes; Peter W Zandstra; Andras Nagy; Jeffrey L Wrana; Benjamin J Blencowe
Journal:  Cell       Date:  2011-09-15       Impact factor: 41.582

3.  rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data.

Authors:  Shihao Shen; Juw Won Park; Zhi-xiang Lu; Lan Lin; Michael D Henry; Ying Nian Wu; Qing Zhou; Yi Xing
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-05       Impact factor: 11.205

Review 4.  iPS cell technology in regenerative medicine.

Authors:  Christopher J Lengner
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

Review 5.  Functional consequences of developmentally regulated alternative splicing.

Authors:  Auinash Kalsotra; Thomas A Cooper
Journal:  Nat Rev Genet       Date:  2011-09-16       Impact factor: 53.242

6.  Novel human TEF-1 isoforms exhibit altered DNA binding and functional properties.

Authors:  S W Jiang; M A Trujillo; M Sakagashira; R A Wilke; N L Eberhardt
Journal:  Biochemistry       Date:  2000-03-28       Impact factor: 3.162

7.  A reprogrammable mouse strain from gene-targeted embryonic stem cells.

Authors:  Matthias Stadtfeld; Nimet Maherali; Marti Borkent; Konrad Hochedlinger
Journal:  Nat Methods       Date:  2009-12-13       Impact factor: 28.547

8.  The short isoform of NF-YA belongs to the embryonic stem cell transcription factor circuitry.

Authors:  Diletta Dolfini; Mario Minuzzo; Giulio Pavesi; Roberto Mantovani
Journal:  Stem Cells       Date:  2012-11       Impact factor: 6.277

9.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

Review 10.  Functional roles of alternative splicing factors in human disease.

Authors:  Benjamin Cieply; Russ P Carstens
Journal:  Wiley Interdiscip Rev RNA       Date:  2015-01-28       Impact factor: 9.957

View more
  28 in total

Review 1.  Roles of Grainyhead-like transcription factors in cancer.

Authors:  S M Frisch; J C Farris; P M Pifer
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

2.  The pioneer factor OCT4 requires the chromatin remodeller BRG1 to support gene regulatory element function in mouse embryonic stem cells.

Authors:  Hamish W King; Robert J Klose
Journal:  Elife       Date:  2017-03-13       Impact factor: 8.140

3.  Assessment of engineered cells using CellNet and RNA-seq.

Authors:  Arthur H Radley; Remy M Schwab; Yuqi Tan; Jeesoo Kim; Emily K W Lo; Patrick Cahan
Journal:  Nat Protoc       Date:  2017-04-27       Impact factor: 13.491

Review 4.  Reprogramming: identifying the mechanisms that safeguard cell identity.

Authors:  Justin Brumbaugh; Bruno Di Stefano; Konrad Hochedlinger
Journal:  Development       Date:  2019-12-02       Impact factor: 6.868

5.  SEASTAR: systematic evaluation of alternative transcription start sites in RNA.

Authors:  Zhiyi Qin; Peter Stoilov; Xuegong Zhang; Yi Xing
Journal:  Nucleic Acids Res       Date:  2018-05-04       Impact factor: 16.971

6.  Rapid and Dynamic Alternative Splicing Impacts the Arabidopsis Cold Response Transcriptome.

Authors:  Cristiane P G Calixto; Wenbin Guo; Allan B James; Nikoleta A Tzioutziou; Juan Carlos Entizne; Paige E Panter; Heather Knight; Hugh G Nimmo; Runxuan Zhang; John W S Brown
Journal:  Plant Cell       Date:  2018-05-15       Impact factor: 11.277

7.  Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease.

Authors:  Lan Lin; Juw Won Park; Shyam Ramachandran; Yida Zhang; Yu-Ting Tseng; Shihao Shen; Henry J Waldvogel; Maurice A Curtis; Richard L M Faull; Juan C Troncoso; Olga Pletnikova; Christopher A Ross; Beverly L Davidson; Yi Xing
Journal:  Hum Mol Genet       Date:  2016-07-04       Impact factor: 6.150

8.  ESRP1 Mutations Cause Hearing Loss due to Defects in Alternative Splicing that Disrupt Cochlear Development.

Authors:  Alex M Rohacek; Thomas W Bebee; Richard K Tilton; Caleb M Radens; Chris McDermott-Roe; Natoya Peart; Maninder Kaur; Michael Zaykaner; Benjamin Cieply; Kiran Musunuru; Yoseph Barash; John A Germiller; Ian D Krantz; Russ P Carstens; Douglas J Epstein
Journal:  Dev Cell       Date:  2017-10-26       Impact factor: 12.270

Review 9.  The distinct roles of zinc finger CCHC-type (ZCCHC) superfamily proteins in the regulation of RNA metabolism.

Authors:  Yishu Wang; Yu Yu; Yidan Pang; Haojun Yu; Wenqi Zhang; Xian Zhao; Jianxiu Yu
Journal:  RNA Biol       Date:  2021-05-04       Impact factor: 4.652

10.  Dynamics of alternative splicing during somatic cell reprogramming reveals functions for RNA-binding proteins CPSF3, hnRNP UL1, and TIA1.

Authors:  Claudia Vivori; Panagiotis Papasaikas; Ralph Stadhouders; Bruno Di Stefano; Anna Ribó Rubio; Clara Berenguer Balaguer; Serena Generoso; Anna Mallol; José Luis Sardina; Bernhard Payer; Thomas Graf; Juan Valcárcel
Journal:  Genome Biol       Date:  2021-06-03       Impact factor: 17.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.